Oetgen Stephen Duane's Form 4 filing
Arxis, Inc. (ARXS) · filed Apr 20, 2026
- Accession no.
- 0001193125-26-164673
- Filed
- Apr 20, 2026
- Trade date
- Apr 17, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $700.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oetgen Stephen DuaneCIK 0002126570 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Class A Common Stock | AGrant or awardAcquired | +5,357 | $0.00 | $0 | 5,357 | Direct | |
| Apr 17, 2026 | Class A Common Stock | PPurchaseAcquired | +25,000 | $28.00 | +$700,000 | 30,357 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.